The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for olaratumab (rmc) (Eli Lilly Australia Pty Ltd)
Active ingredients
olaratumab (rmc)
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology